A NSW Government website

On

Vascular Surgery Research

From the early years of vascular surgery in Australia, Concord Repatriation General Hospital has a reputation for innovative surgical research.

In recent years, our research has focused on cross-discipline collaborative research and population-wide surgical outcomes. Our population-based research evaluates the impact of age-related illness on vascular outcomes. Collaborating with the geriatric medicine department, we have designed and evaluated the Geri-CoV service, a shared-care model designed to enhance surgical outcomes and decrease complications in older patients admitted for vascular issues.

Our focus on patient centred outcomes is developed through qualitative research projects evaluating patient experiences with chronic-limb threatening ischaemia and amputation. We also are active in a number of translational research projects, evaluating new and innovative therapies to treat vascular disease. Concord has been the lead site for multicentre trainee collaborative research trials in vascular illness, in particular the Australian lead site for the COVID-19 Vascular sERvice (COVER) study.

The unit is very engaged in teaching, both at medical student and for doctors in training. We have research projects related to medical education and development. Members of our research team have active teaching roles with the University of Sydney and Royal Australasian College of Surgeons. 

Our Research Team

Dr Richard Kerdic Vascular Surgeon, Clinical Researcher, Head of Department
Dr Sarah Aitken Vascular Surgeon, Clinical Academic, Clinical Researcher, Co-chair Concord Institute of Academic Surgery
Dr Robert Tang Vascular Surgeon, Clinical Researcher, Coordinator University of Sydney MS vascular unit
Dr Saissan Rajendran Vascular Surgeon, Clinical Researcher, MPhil candidate
Dr Sue Monaro Vascular Clinical Nurse Consultant, Clinical Researcher

Selected Grants

Amount awarded Grant and project details
$1,400,000 MRFF, 2022-2025
Beyond Country of Birth: Ethnicity and Cardiovascular Health in NSW
Investigators: Stanaway F, Aitken S, Kritharides L, Wilson A, Schneider C, Zhu L, Jorm L, Dickson M, Kelly P, Soltani S

Our Publications

2024

Telianidis S, Aitken SJ. The prevalent causes of death in patients with peripheral artery disease undergoing revascularisation or amputation. Vascular. 2024 Dec;32(6):1276-1284. doi: 10.1177/17085381241236562.
Aitken SJ, James S, Lawrence A, Glover A, Pleass H, Thillianadesan J, Monaro S, Hitos K, Naganathan V; SHP Perioperative CAG collaborators. Codesign of health technology interventions to support best-practice perioperative care and surgical waitlist management. BMJ Health Care Inform. 2024 Mar 12;31(1):e100928. doi: 10.1136/bmjhci-2023-100928. 
Zhu A, Tang R, Rajendran S, Hajian H, Aitken SJ. Prescriber decision-making on antithrombotic therapy after endovascular intervention for peripheral artery disease: a protocol for a discrete choice experiment. BMJ Open. 2024 Mar 20;14(3):e079668. doi: 10.1136/bmjopen-2023-079668. 
Narayanan A, Musicki K, Aitken SJ, Taumoepeau L, Khashram M. Restoring flow to the Aotearoa New Zealand vascular workforce pipeline requires tangible strategic interventions. ANZ J Surg. 2024 May;94(5):782-784. doi: 10.1111/ans.18990.
Zhu A, Aitken SJ. Failing in the system or systemic failure? The inherent tension within surgical trainee underperformance and remediation. Am J Surg. 2024 Aug;234:9-10. doi: 10.1016/j.amjsurg.2024.03.016. 
Zhu A, Rajendran S, Hajian H, Aitken S. Patient Factors Influencing Prescription of Antithrombotic Medication After Lower Limb Endovascular Intervention. Eur J Vasc Endovasc Surg. 2024 Oct;68(4):510-518. doi: 10.1016/j.ejvs.2024.05.034.
Sena Board M, McBride KE, Solomon MJ, Aitken SJ, Rickard MJFX, Collins JM, Steffens D. Australian surgeon attitudes and experiences towards completing a higher degree by research. Aust Health Rev. 2024 Aug;48(4):406-413. doi: 10.1071/AH23230.
Cartland SP, Patil MS, Kelland E, Le N, Boccanfuso L, Stanley CP, Cholan PM, Dona MI, Patrick R, McGrath J, Su QP, Alwis I, Ganss R, Powell JE, Harvey RP, Pinto AR, Griffith TS, Loa J, Aitken SJ, Robinson DA, Patel S, Kavurma MM. The generation of stable microvessels in ischemia is mediated by endothelial cell derived TRAIL. Sci Adv. 2024 Oct 4;10(40):eadn8760. doi: 10.1126/sciadv.adn8760.